li>Provide education as determined by account strategy to:
Referring physicians about current DRE treatment gaps, quality measures, and available LIVN resources,
Physicians/clinicians and staff on new product releases of device systems and features, including both hardware and software modifications,
Fellows and residents on DRE treatments and VNS therapy,
Account staff on post-implant VNS therapy and product support,
Patients and families on post-implant VNS therapy and product support in the presence of the provider or as directed by the provider.
LivaNova Neuromodulation:
As pioneers of the VNS (Vagus Nerve Stimulation) Therapy system, LivaNova continues to advance medical device solutions for patients affected by Drug-Resistant Epilepsy (DRE) and Difficult-to-Treat Depression (DTD).